Moderna Inc (MRNA) Moderna (NASDAQ: MRNA) Inks Agreement with Lonza Moderna, Inc. (NASDAQ: MRNA) disclosed that it has inked an agreement with Lonza to back drug substance production for its global supply chain. The deal will build a new production line at Lonza’s Geleen site in the Netherlands.
